Thimble Point (THMA) and Pear Therapeutics Arrange Backstop Funding

Thimble Point Acquisition Corp, Inc. (NASDAQ: THMA) and Pear Therapeutics, announced this morning that they have arranged an “up to $50 million” backstop funding ahead of their scheduled shareholder vote later this month. THMA previously disclosed a $125 million PIPE at combination announcement with a large roster of investors that includes 5AM Ventures, Arboretum Ventures,
Read More